Rezultati - David Irwin

Refine Results
  1. 1
    The Splenic Syndrome in Individuals with Sickle Cell Trait

    The Splenic Syndrome in Individuals with Sickle Cell Trait od Jessica Goodman, Kathryn Hassell, David Irwin, Ewa H. Witkowski, Rachelle Nuss

    Izdano 2014
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    RhoGTPase in Vascular Disease

    RhoGTPase in Vascular Disease od Derek Strassheim, Evgenia Gerasimovskaya, David Irwin, Edward C. Dempsey, Kurt R. Stenmark, Vijaya Karoor

    Izdano 2019
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Phase II Trial of Weekly Vinorelbine and Trastuzumab as First-Line Therapy in Patients with HER2+ Metastatic Breast Cancer

    Phase II Trial of Weekly Vinorelbine and Trastuzumab as First-Line Therapy in Patients with HER2+ Metastatic Breast Cancer od Mohammad Jahanzeb, Joanne Mortimer, Furhan Yunus, David Irwin, James L. Speyer, Alan J. Koletsky, Paula Klein, Tariq Sabir, Lori Kronish

    Izdano 2002
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    A Single-Center Experience with a Shear-Thinning Conformable Embolic

    A Single-Center Experience with a Shear-Thinning Conformable Embolic od Koustav Pal, Milan Patel, Stephen Chen, Bruno C. Odisio, Zeyad Metwalli, Judy U. Ahrar, David Irwin, Rahul A. Sheth, J. Kuban

    Izdano 2024
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Depletion of haptoglobin and hemopexin promote hemoglobin-mediated lipoprotein oxidation in sickle cell disease

    Depletion of haptoglobin and hemopexin promote hemoglobin-mediated lipoprotein oxidation in sickle cell disease od Ayla Yalamanoglu, Jeremy W. Deuel, Ryan Hunt, Jin Hyen Baek, Kathryn L. Hassell, Katie Redinius, David Irwin, Dominik J. Schaer, Paul W. Buehler

    Izdano 2018
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Nrf2 activation: A potential strategy for the prevention of acute mountain sickness

    Nrf2 activation: A potential strategy for the prevention of acute mountain sickness od Christina Lisk, Joe M. McCord, Swapan K. Bose, Timothy J. Sullivan, Zoe Loomis, Eva Nozik‐Grayck, Thies Schroeder, Karyn L. Hamilton, David Irwin

    Izdano 2013
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    Hemoglobin-induced lung vascular oxidation, inflammation, and remodeling contribute to the progression of hypoxic pulmonary hypertension and is attenuated in rats with repeated-dose haptoglobin administration

    Hemoglobin-induced lung vascular oxidation, inflammation, and remodeling contribute to the progression of hypoxic pulmonary hypertension and is attenuated in rats with repeated-dos... od David Irwin, Jin Hyen Baek, Kathryn L. Hassell, Rachelle Nuss, Paul Eigenberger, Christina Lisk, Zoe Loomis, Joanne Maltzahn, Kurt R. Stenmark, Eva Nozik‐Grayck, Paul W. Buehler

    Izdano 2015
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    Bortezomib therapy alone and in combination with dexamethasone for previously untreated symptomatic multiple myeloma

    Bortezomib therapy alone and in combination with dexamethasone for previously untreated symptomatic multiple myeloma od Sundar Jagannath, Brian G.M. Durie, Jeffrey L. Wolf, Elber S. Camacho, David Irwin, Jose Lutzky, Marti McKinley, Eli Gabayan, Amitabha Mazumder, David P. Schenkein, John Crowley

    Izdano 2005
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Clinical factors predictive of outcome with bortezomib in patients with relapsed, refractory multiple myeloma

    Clinical factors predictive of outcome with bortezomib in patients with relapsed, refractory multiple myeloma od Paul G. Richardson, Bart Barlogie, James R. Berenson, Seema Singhal, Sundar Jagannath, David Irwin, S. Vincent Rajkumar, Teru Hideshima, Hugh Xiao, Dixie Esseltine, David P. Schenkein, Kenneth C. Anderson

    Izdano 2005
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    Bortezomib is associated with better health‐related quality of life than high‐dose dexamethasone in patients with relapsed multiple myeloma: results from the APEX study

    Bortezomib is associated with better health‐related quality of life than high‐dose dexamethasone in patients with relapsed multiple myeloma: results from the APEX study od Stephanie J. Lee, Paul G. Richardson, Pieter Sonneveld, Michael W. Schuster, David Irwin, Jesús F. San Miguel, Bruce Crawford, Joseph M. Massaro, Ravinder Dhawan, Sanjay Gupta, Kenneth C. Anderson

    Izdano 2008
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Free hemoglobin induction of pulmonary vascular disease: evidence for an inflammatory mechanism

    Free hemoglobin induction of pulmonary vascular disease: evidence for an inflammatory mechanism od Paul W. Buehler, Jin Hyen Baek, Christina Lisk, Ian Connor, Timothy J. Sullivan, Douglas J. Kominsky, Susan M. Majka, Kurt R. Stenmark, Eva Nozik‐Grayck, J. Bonaventura, David Irwin

    Izdano 2012
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    Extended follow‐up of a phase 2 trial of bortezomib alone and in combination with dexamethasone for the frontline treatment of multiple myeloma

    Extended follow‐up of a phase 2 trial of bortezomib alone and in combination with dexamethasone for the frontline treatment of multiple myeloma od Sundar Jagannath, Brian G.M. Durie, Jeffrey L. Wolf, Elber S. Camacho, David Irwin, Jose Lutzky, Marti McKinley, Phyllis Potts, Afshin Eli Gabayan, Amitabha Mazumder, John Crowley, Robert Vescio

    Izdano 2009
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension

    Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension od Douglas D. Lemon, Todd R. Horn, Maria A. Cavasin, Mark Y. Jeong, Kurt Haubold, Carlin S. Long, David Irwin, Sylvia A. McCune, Eunhee Chung, Leslie A. Leinwand, Timothy A. McKinsey

    Izdano 2011
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial

    Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial od Meinolf Karthaus, Albrecht Kretzschmar, H. Kröning, M. Biakhov, David Irwin, Norbert Marschner, C. Slabber, George Fountzilas, A. Garin, N.G.F. Abecasis, W. Baronius, G. Steger, T Südhoff, C. Giorgetti, Peter Reichardt

    Izdano 2005
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    Safety and efficacy of bortezomib in high‐risk and elderly patients with relapsed multiple myeloma

    Safety and efficacy of bortezomib in high‐risk and elderly patients with relapsed multiple myeloma od Paul G. Richardson, Pieter Sonneveld, Michael W. Schuster, David Irwin, Edward A. Stadtmauer, Thierry Façon, Jean‐Luc Harousseau, Dina Ben‐Yehuda, Sagar Lonial, Jesús F. San Miguel, Jamie Cavenagh, Kenneth C. Anderson

    Izdano 2007
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension

    Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension od Eva Nozik‐Grayck, Crystal Woods, Joann M. Taylor, Richard K.P. Benninger, R. Daniel Johnson, Leah R. Villegas, Kurt R. Stenmark, David G. Harrison, Susan M. Majka, David Irwin, Kathryn N. Farrow

    Izdano 2014
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  17. 17
    A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma

    A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma od Sundar Jagannath, Bart Barlogie, James R. Berenson, David S. Siegel, David Irwin, Paul G. Richardson, Rubén Niesvizky, Raymond Alexanian, Steven Limentani, Melissa Alsina, Julian Adams, Michael Kauffman, Dixie‐Lee Esseltine, David P. Schenkein, Kenneth C. Anderson

    Izdano 2004
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  18. 18
    The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multiple myeloma

    The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multip... od Rubén Niesvizky, Paul G. Richardson, S. Vincent Rajkumar, Morton Coleman, Laura Rosiñol, Pieter Sonneveld, Michael W. Schuster, David Irwin, Edward A. Stadtmauer, Thierry Façon, Jean‐Luc Harousseau, Anthony Boral, Dixie‐Lee Esseltine, Kenneth C. Anderson, Joan Bladé

    Izdano 2008
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  19. 19
    A potential role for reactive oxygen species and the HIF-1α–VEGF pathway in hypoxia-induced pulmonary vascular leak

    A potential role for reactive oxygen species and the HIF-1α–VEGF pathway in hypoxia-induced pulmonary vascular leak od David Irwin, Joe M. McCord, Eva Nozik‐Grayck, Ginny Beckly, Ben Foreman, Timothy J. Sullivan, Molly White, Joseph T. Crossno, Damian M. Bailey, Sonia C. Flores, Susan M. Majka, Dwight J. Klemm, Martha C. Tissot van Patot

    Izdano 2009
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  20. 20
    Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myeloma

    Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myeloma od Paul G. Richardson, Sundar Jagannath, Mohamad A. Hussein, James R. Berenson, Seema Singhal, David Irwin, Stephanie Williams, William Bensinger, Ashraf Badros, Robert Vescio, Laurie Kenvin, Zhinuan Yu, Marta Olesnyckyj, Jerome B. Zeldis, Robert Knight, Kenneth C. Anderson

    Izdano 2009
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: